News

Norwegian Salmon® is developed and produced in Norway Pharmatech on Rolvsøy outside Fredrikstad is one of Europe's largest producers of health food, medicines and pharmaceutical products. Pharmatech has its own laboratory for internal control at MultiLab AS Østfold with 3 employed biochemists, a pharmacist and a microbiologist. Pharmatech has broad expertise with over 170 employees spread over 3 factories.Each product is manufactured to the highest standards. Therefore, everyone on the team is an expert in their field with many years of experience, which ensures products of the highest quality.Pharmatech is HACCP and FDA approved, with state-of-the-art testing and R&D facilities...

Our genesis In the vast, vibrant market of omega-3 supplements, the emergence of Norwegian Salmon was sparked by a clear vision – to create a uniquely Norwegian omega-3 product that stands out for its quality and sustainability. Recognizing the global market's saturation with omega-3 sourced from far-off lands like Chile and Peru, we turned to Norway's own bountiful seas. Here, in the pristine waters of the Norwegian fjords, we found the exceptional quality of salmon and cod that now forms the foundation of our product. Norwegian Salmon is born out of a commitment to leverage our local maritime riches, ensuring...

Research published in the journal Food & Function demonstrates that children with elevated levels of omega-3 fatty acids EPA and DHA in their blood exhibit less DNA damage compared to those with lower levels. This Brazilian study investigated blood levels of several nutrients—omega-3s EPA and DHA, vitamin B12, beta-carotene, and riboflavin—in a cohort of 140 healthy children and adolescents.    The study's methodology included body measurements, energy intake assessments, and blood sampling. The researchers employed single-cell gel electrophoresis (comet assay), a widely used method to evaluate DNA damage, aiming to identify correlations between blood concentrations of vitamins and omega-3 fatty...

Boosting the omega-3 levels in a pregnant woman's blood may lower her child's risk of developing asthma, suggests a groundbreaking study from Denmark. This evidence adds to the growing support for universal DHA supplementation among pregnant women. According to the CDC, asthma affects 8.6% of children under 18 years old (6.3 million) in the U.S. alone, costing approximately $56 billion annually.   As the leading chronic disease in children, the main cause of missed school days, and the third leading cause of hospital stays for children, asthma represents a significant concern for both children and adults. Simple dietary changes that...